Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mizoribine plus azathioprine for primary sclerosing cholangitis
jRCTs051180120Completed
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of mizoribine and azathioprine in Primary Sclerosing Cholangitis (PSC). Primary endpoint: Liver function tests. Started Apr 2012; status: completed.
02
Drugs
mizoribineazathioprine
03
Conditions
Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on jRCTs051180120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180120.